AMREP Corporation closed fiscal 2026 with net income of $10.3 million on $52.8 million of revenue - down 19% in earnings despite a 6% rise in the top line, a divergence that the headline misses but the ledgers do not. The driver was a tax provision that nearly quadrupled to $3.8 million (from $1.0 million the year before) on an effective rate of 27% that, in fiscal 2025, had been deflated by a one-time $1.2 million reclassification tied to the wind-up of the company's defined-benefit pension. Strip the calendar effect, and the operating story looks different: operating income was effectively flat at $12.4 million, operating cash flow rose 26% to $12.9 million, and the company ended the year with $52.7 million of cash and equivalents against $18,000 of debt - a balance sheet that requires no narrative to defend.
The operating story, however, is two-toned. The homebuilding segment delivered - 65 homes closed at a $441,000 average price (up from 50 at $425,000) and a 24% gross margin (up 300 basis points), with the company leaning into New Mexico's third-largest city. The land development segment ran the other way: land-sale revenue fell 20% to $20.6 million on 587 acres sold (versus 719 the year before), with developed residential revenue down 37% to $13.8 million. Management has guided that fiscal 2027 land-sale revenue will fall again, citing deliberate pace-slowing and project deferrals in response to entitlement, contractor and infrastructure delays. The company has 75 homes in production and 24 of them under contract for $13.0 million of expected revenue, but the segment that has historically produced the highest-margin transactions is the one being deliberately throttled.
The open question the quarter raises is whether AMREP can convert the run-rate it has quietly built - the cash, the productive homebuilding, the 16,200 acres and 55,000 acres of mineral rights in Sandoval County - into fiscal 2027 net income above the 2025 base of $12.7 million, despite the land-development headwind management has already named. The 0.84x price-to-book valuation, the 11.8x trailing P/E, and the 46% insider ownership signal that the market is not pricing a recovery. The monitors below are the dates and data points that decide whether the throttling is the right call or the first sign that the land bank is past its prime.